Health Care

South Plainfield-based PTC Therapeutics Inc. announced it has acquired Agilis Biotherapeutics Inc., a biotechnology company focused on gene therapies for rare genetic disorders of the central nervous system. "We are excited to complete the acquisition...

In the U.S., one in eight women and one in 1,000 men will get breast cancer. Yet, according to Kelly E. Nagle, executive director of Susan G. Komen North Jersey in Parsippany, just under half...

Locked in a battle with a severe opioid epidemic, the local addiction treatment space is coming up with new ways of ensuring people are put on a path toward recovery — not behind bars. Charles...

Leaders at local mental health and drug treatment agencies all agree that the spotlight put on the opioid epidemic has brought the severity of the problem out of the dark. Especially in the suburbs. Last year,...

Bacharach Institute for Rehabilitation has opened its 18th satellite location, a physical therapy center located along Route 70 in Marlton. The Pomona-based inpatient and outpatient rehab hospital now has 18 physical therapy centers in four...

ODH Inc., a Princeton-based health technology company, announced Wednesday it has appointed Remy Sukhija its new interim CEO. Sukhija, who has more than 25 years of experience in biotechnology, pharmaceuticals and startups, will be responsible...

U.S. Rep. Josh Gottheimer met with representatives of small businesses and industry leaders last week to understand the biggest red tape issues that medical device and life sciences businesses in his district face. The group,...

It was a synergistic opportunity waiting to be seized, Steve Rosenthal said. “In my opinion, there is no better way to achieve wellness than to work out,” Rosenthal said. “Healthy employees mean less claims; less...

Lyndhurst-based Vitals, a health care savings company, announced Tuesday that Robert Benedetto has been named senior vice president, client engagement. Benedetto will be responsible for heading the engagement team that works closely with clients to optimize...

Danish drugmaker Novo Nordisk A/S, which has its U.S. headquarters in Plainsboro, announced it has acquired British company Ziylo Ltd. and its glucose binding molecule platform. The transaction included an upfront payment and potential contingency...